ScienceDaily·3 min read·medium
New weight loss pill beats oral Ozempic in major trial
✦AI Summary
A new oral weight-loss drug, orforglipron, has outperformed injectable semaglutide in clinical trials, offering a more convenient alternative for patients. The drug aims to address the logistical and comfort issues associated with current GLP-1 injectable treatments.
A new type of daily pill has proven more effective for weight loss and blood sugar control than its currently available counterparts, according to a recent trial. The drug, known as orforglipron, could be a game-changer in the rapidly expanding oral weight-loss drug market.
healthsciencebusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in